Ï㽶ÊÓƵ

2025 Membership (PDF)

2026 Proposed Charges

1. The Prescription Drug Coverage (B) Working Group will:
   
   1. Serve as a forum to educate state insurance regulators on issues related to prescription drug coverage regulation and stakeholders in the prescription drug ecosystem.
   2. Gather and share information, best practices, experience, and data to inform and support dialogue and information-sharing among state insurance regulators on issues related to prescription drug coverage regulation, such as pharmaceutical drug pricing and transparency, formularies, pharmacy payments, pharmacy benefit managers (PBMs), and coverage options.
   3. Maintain a current listing of all prescription drug coverage laws and regulations and case law that fall under the purview of state-based insurance.
   4. Disseminate materials and reports via the Ï㽶ÊÓƵ to the states and the U.S. territories wishing to use the information gathered by the Working Group.
   5. Monitor, facilitate, and coordinate with the states and federal agencies to ensure compliance and enforcement efforts regarding prescription drug coverage and PBMs.
   6. Provide assistance and input to the Market Regulation and Consumer Affairs (D) Committee and/or any of its groups, as necessary, related to PBM enforcement.

2025 Revised Charges

1. The Prescription Drug Coverage (B) Working Group will:
   
   1. Serve as a forum to educate state insurance regulators on issues related to prescription drug coverage regulation and stakeholders in the prescription drug ecosystem.
   2. Gather and share information, best practices, experience, and data to inform and support dialogue and information-sharing among state insurance regulators on issues related to prescription drug coverage regulation, such as pharmaceutical drug pricing and transparency, formularies, pharmacy payments, pharmacy benefit managers (PBMs), and coverage options.
   3. Maintain a current listing of all prescription drug coverage laws and regulations and case law as fall under the purview of state-based insurance.
   4. Disseminate materials and reports via the Ï㽶ÊÓƵ to the states and the U.S. territories wishing to use the information gathered by the Working Group.
   5. Monitor, facilitate, and coordinate with the states and federal agencies to ensure compliance and enforcement efforts regarding prescription drug coverage and PBMs.
   6. Provide assistance and input to the Market Regulation and Consumer Affairs (D) Committee and/or any of its groups, as necessary, related to PBM enforcement.